ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Some Long-Term Survivors At Higher Risk Of Stroke

November 24, 2006

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 16, 1998

Also in this 8-page issue: Senate Labor-HHS finds an extra $1 billion for NIH; Appropriations Committee reports bill to Senate.

July 15, 2005

MIT’s Robert Weinberg Says He Doesn’t Advise Young People To Enter Career In Cancer Research.

April 7, 2006

Tobacco Council Announces 12 New Awards, Six Relating To Smoking

August 2, 1974

Ruckdeschel To Direct Nevada Cancer Institute

February 6, 2009